Dow Down1.29% Nasdaq Down3.25%

Amyris, Inc. (AMRS)

-NasdaqGS
1.45 0.00(0.00%) Feb 5, 3:59PM EST
ProfileGet Profile for:
Amyris, Inc.
5885 Hollis Street
Suite 100
Emeryville, CA 94608
United States - Map
Phone: 510-450-0761
Fax: 510-225-2645
Website: http://www.amyris.com

Details 
Index Membership:N/A
Sector:Basic Materials
Industry:Specialty Chemicals
Full Time Employees:405

Business Summary 

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company applies its industrial synthetic biology platform to design microbes and primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and various materials for performance materials market; renewable fuels for transportation fuels market; and base oils for lubricants market. It has a collaboration partnership with Total to commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Amyris, Inc.

Corporate Governance 
Amyris, Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. John G. Melo , 50
Chief Exec. Officer, Pres and Director
910.00K0.00
Dr. Joel R. Cherry Ph.D., 55
Pres of R&D
465.00K0.00
Mr. Nicholas S. Khadder , 42
Sr. VP, Gen. Counsel and Corp. Sec.
385.00K0.00
Mr. Raffi Mark Asadorian , 47
Chief Financial Officer
N/AN/A
Peter Denardo ,
Director of Investor Relations & Corp. Communications
N/AN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders